‘Recently recovered COVID-19 patients produce virus-specific antibodies’
The study also indicates which parts of the virus are most effective at triggering these immune responses, and should therefore be targeted by potential vaccines.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario